- Home
- SLAB vs TERN Comparison
SLAB vs TERN Comparison
Compare SLAB & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLAB | TERN |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.8B |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SLAB | TERN |
|---|---|---|
| Price | $135.32 | $42.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $144.90 | $48.60 |
| AVG Volume (30 Days) | 279.8K | ★ 4.7M |
| Earning Date | 02-03-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $742,807,000.00 | N/A |
| Revenue This Year | $36.85 | N/A |
| Revenue Next Year | $17.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.10 | N/A |
| 52 Week Low | $82.82 | $1.87 |
| 52 Week High | $160.00 | $48.26 |
Technical Indicators
Market Signals| Indicator | SLAB | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 69.41 |
| Support Level | $131.46 | $39.15 |
| Resistance Level | $139.23 | $45.17 |
| Average True Range (ATR) | 4.66 | 3.70 |
| MACD | -0.44 | -0.61 |
| Stochastic Oscillator | 21.17 | 71.79 |
Price Performance
Historical ComparisonAbout SLAB Silicon Laboratories Inc.
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.